Molecular analysis reveals heterogeneity of mouse mammary tumors conditionally mutant for Brca1.
about
Targeting serous epithelial ovarian cancer with designer zinc finger transcription factorsTargeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance.Novel role of Engrailed 1 as a prosurvival transcription factor in basal-like breast cancer and engineering of interference peptides block its oncogenic function.Choosing a mouse model: experimental biology in context--the utility and limitations of mouse models of breast cancer.Emerging drug discovery approaches for selective targeting of "precursor" metastatic breast cancer cells: highlights and perspectivesGene expression analysis of in vitro cocultures to study interactions between breast epithelium and stroma.Consistent gene expression profiles in MexTAg transgenic mouse and wild type mouse asbestos-induced mesothelioma.Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics.Epithelial-mesenchymal transition in mouse mammary tumorigenesis.The roles of ncRNAs and histone-modifiers in regulating breast cancer stem cells.MicroRNA-206 is differentially expressed in Brca1-deficient mice and regulates epithelial and stromal cell compartments of the mouse mammary glandGermline mutation of Brca1 alters the fate of mammary luminal cells and causes luminal-to-basal mammary tumor transformation.Histological subtypes of mouse mammary tumors reveal conserved relationships to human cancers.Analysis of Brca1-deficient mouse mammary glands reveals reciprocal regulation of Brca1 and c-kit.MiR-29b-1-5p is altered in BRCA1 mutant tumours and is a biomarker in basal-like breast cancer
P2860
Q24605597-2FC25F72-C6E3-45E6-A265-1EF9696AEB03Q34208986-DB11E158-85A4-4331-929B-57C79D081EECQ34285190-0512B39F-BF42-4D64-9CB8-1BC57D9BB2C6Q35234634-576F3A9B-68CA-4864-B59D-6F2D0D749244Q35485571-5518EB8B-2007-4C85-9743-317EB1C9B9ECQ35616195-00EA0D7D-3D1D-4816-A565-DFC5F7DBE5C1Q35872350-3F87F846-F127-4AB4-A888-25FFD1BA6D58Q36643063-E3556B09-7C75-4C9E-B28D-C1911C6D8A0FQ37620377-DE71E0DA-BA91-48E0-ADDD-B1EBDD894D95Q38263985-D7A87253-C98F-4553-B4A1-B8BCCD4B86EEQ40747141-A95A9314-942D-4B6C-93AA-711FA8A15AD1Q42509342-AFD5DD6C-3392-4DDB-B209-3634BD2BB1E1Q48218331-1EB70060-8217-4F3E-A397-13A34BC2180DQ52605706-96DEA811-6EBC-4C96-83B5-B55F99239103Q57493676-56904657-DBAD-4DB8-98F5-2DA0BFD51EA8
P2860
Molecular analysis reveals heterogeneity of mouse mammary tumors conditionally mutant for Brca1.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Molecular analysis reveals het ...... onditionally mutant for Brca1.
@ast
Molecular analysis reveals het ...... onditionally mutant for Brca1.
@en
type
label
Molecular analysis reveals het ...... onditionally mutant for Brca1.
@ast
Molecular analysis reveals het ...... onditionally mutant for Brca1.
@en
prefLabel
Molecular analysis reveals het ...... onditionally mutant for Brca1.
@ast
Molecular analysis reveals het ...... onditionally mutant for Brca1.
@en
P2093
P2860
P356
P1433
P1476
Molecular analysis reveals het ...... onditionally mutant for Brca1.
@en
P2093
Ana I Robles
Jason I Herschkowitz
Lyuba Varticovski
Melinda G Hollingshead
Miriam R Anver
Mollie H Wright
P2860
P2888
P356
10.1186/1476-4598-7-29
P577
2008-04-07T00:00:00Z
P5875
P6179
1015672704